Implicit|||||||||||Expansion|||||||||||0..265|0|Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1 Abstract Background : CC Chemokine Receptor 3 ( CCR3 ) , the major chemokine receptor expressed on eosinophils , binds promiscuously to several ligands including eotaxins 1 , 2 , and 3 .||||||||267..464|1|Even though the only cells that consistently accumulate following eotaxin administration in vivo are myeloid cells ( primarily eosinophils ) , other cell types have recently been shown to express CCR3 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||466..560|2|It is therefore important to elucidate the molecular mechanisms regulating receptor expression .||||||||562..702|3|Results : In order to define regions responsible for CCR3 transcription , a DNAse hypersensitive site was identified in the vicinity of exon 1 .|||||||||||||
Implicit|||||||||||Contingency|||||||||||562..702|3|Results : In order to define regions responsible for CCR3 transcription , a DNAse hypersensitive site was identified in the vicinity of exon 1 .||||||||704..834|4|Coupled with our previous data implicating exon 1 in CCR3 transcription , we hypothesized that transcription factors bind to exon-1 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||704..834|4|Coupled with our previous data implicating exon 1 in CCR3 transcription , we hypothesized that transcription factors bind to exon-1 .||||||||836..944|5|Electrophoretic mobility shift analysis revealed that nuclear proteins in eosinophilic cells bound to exon 1 .|||||||||||||
EntRel||||||||||||||||||||||946..1039|6|Furthermore , antibody interference and mutation studies demonstrated GATA-1 binding to exon 1 .||||||||1041..1218|7|In order to test the 1.6-kb CCR3 promoter element ( that includes exon 1 ) for in vivo function , this region was used to generate transgenic mice that expressed a reporter protein .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1041..1218|7|In order to test the 1.6-kb CCR3 promoter element ( that includes exon 1 ) for in vivo function , this region was used to generate transgenic mice that expressed a reporter protein .||||||||1220..1327|8|Strong transgene expression was achieved , with the pattern of expression suggesting a broad acting promoter .|||||||||||||
EntRel||||||||||||||||||||||1220..1327|8|Strong transgene expression was achieved , with the pattern of expression suggesting a broad acting promoter .||||||||1329..1393|9|Conclusion : The transcription factor GATA-1 binds to CCR3 exon 1 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1482..1635|11|Background CCR3 , the eotaxin receptor , is the major chemokine receptor expressed on eosinophils , basophils and a subpopulation of Th2 lymphocytes [ 1-10 ] .||||||||1637..1831|12|Recently , CCR3 has been shown to be upregulated on neutrophils and monocytoid U937 cells by interferons in vitro and to be expressed by endothelial cells , epithelial cells and mast cells [ 11-16 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||1833..2072|13|The relevance of these findings and the function of CCR3 on non-leukocytes remain to be elucidated since the only cells that consistently accumulate following eotaxin administration in vivo are myeloid cells ( primarily eosinophils ) [ 17-20 ] .||||||||2076..2202|14|To date , the complete mRNA and genomic organization of only a limited number of chemokine receptors has been described [ 21-26 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2076..2202|14|To date , the complete mRNA and genomic organization of only a limited number of chemokine receptors has been described [ 21-26 ] .||||||||2204..2331|15|These studies have shown that the 5 ' untranslated region ( 5 ' UTR ) can be complex and contain up to 11 exons as in the CXCR2 gene .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2333..2455|16|As a result , alternative splicing and transcription directed by multiple promoters can give rise to variable mRNA isoforms .||||||||2457..2618|17|The function of these 5 ' untranslated exons has not been examined except for a single study focused on CCR2 , demonstrating a transcriptional role for exon 1 [ 24 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2457..2618|17|The function of these 5 ' untranslated exons has not been examined except for a single study focused on CCR2 , demonstrating a transcriptional role for exon 1 [ 24 ] .||||||||2620..2724|18|We have previously characterized the genomic structure and promoter function of the human CCR3 gene [ 27 ] .|||||||||||||
EntRel||||||||||||||||||||||2620..2724|18|We have previously characterized the genomic structure and promoter function of the human CCR3 gene [ 27 ] .||||||||2726..2829|19|The CCR3 gene contains at least 4 exons that give rise to multiple mRNA species by alternative splicing .|||||||||||||
EntRel||||||||||||||||||||||2726..2829|19|The CCR3 gene contains at least 4 exons that give rise to multiple mRNA species by alternative splicing .||||||||2831..2976|20|The first 1.6 kb of the 5 ' flanking region of exon 1 had strong promoter activity in eosinophilic , lymphoid and respiratory epithelial cell lines .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2831..2976|20|The first 1.6 kb of the 5 ' flanking region of exon 1 had strong promoter activity in eosinophilic , lymphoid and respiratory epithelial cell lines .||||||||2978..3144|21|Deletion analysis revealed differential regulation of the CCR3 promoter in eosinophilic and epithelial cell lines suggesting the presence of lineage-specific elements .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2978..3144|21|Deletion analysis revealed differential regulation of the CCR3 promoter in eosinophilic and epithelial cell lines suggesting the presence of lineage-specific elements .||||||||3146..3205|22|Interestingly , exon 1 enhanced the activity of the promoter .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3146..3205|22|Interestingly , exon 1 enhanced the activity of the promoter .||||||||3207..3409|23|Since our initial characterization , two other groups have studied the CCR3 promoter [ 28,29 ] ; however , their studies focused on lymphocytic and monocytic cell lines , respectively , rather than eosinophils .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3207..3409|23|Since our initial characterization , two other groups have studied the CCR3 promoter [ 28,29 ] ; however , their studies focused on lymphocytic and monocytic cell lines , respectively , rather than eosinophils .||||||||3411..3516|24|Scotet et al. [ 29 ] demonstrated that the human CCR3 promoter is active in vitro in lymphocytic cell lines .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3518..3621|25|They also demonstrate a role for chromatin remodeling in the regulation of CCR3 expression in Th2 cells .||||||||3623..3864|26|Vijh et al. [ 28 ] demonstrated that the human CCR3 promoter is active in monocytic cell lines and defined the minimal promoter that consists of a downstream promoter element ( DPE ) , a common element in Drosophila genes , but rare in human genes .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3866..3951|27|This element is upstream ( 50 bp ) of the exon 1 sequence studied in the current report .||||||||3955..4085|28|It has been reported that 5 ' untranslated exons , and sometimes introns , can regulate the expression of genes in two different ways .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3955..4085|28|It has been reported that 5 ' untranslated exons , and sometimes introns , can regulate the expression of genes in two different ways .||||||||4087..4164|29|An untranslated sequence can act as a tissue-specific translational regulator .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4087..4164|29|An untranslated sequence can act as a tissue-specific translational regulator .||||||||4166..4341|30|A striking example is the gonadotropin releasing hormone gene which is transcribed in multiple tissue , but can not be translated due to the lack of specific intron removal [ 30 ] .|||||||||||||
EntRel||||||||||||||||||||||4343..4423|31|Alternatively , untranslated regions ( UTR ) can facilitate transcription of a gene .||||||||4425..4574|32|Examples include a GATA-1 site in the 5 ' - UTR of the γ-globin gene , an HNF-1 site in the plasminogen gene and a C/EBP site in the CCR2 gene [ 24,31,32 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4425..4574|32|Examples include a GATA-1 site in the 5 ' - UTR of the γ-globin gene , an HNF-1 site in the plasminogen gene and a C/EBP site in the CCR2 gene [ 24,31,32 ] .||||||||4576..4792|33|While the mechanism of action is not completely clear , it is thought that transcription factors binding to untranslated regions affect transcription of the gene through interactions with the RNA transcription complex .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4576..4792|33|While the mechanism of action is not completely clear , it is thought that transcription factors binding to untranslated regions affect transcription of the gene through interactions with the RNA transcription complex .||||||||4794..4862|34|The role of untranslated exons in the CCR3 gene has not been studied .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4794..4862|34|The role of untranslated exons in the CCR3 gene has not been studied .||||||||4864..4990|35|In this report , DNase I hypersensitivity identified a major hypersensitive site located in the vicinity of untranslated exon 1 .|||||||||||||
Implicit|||||||||||Contingency|||||||||||5401..5481|39|Thus , we performed DNase I hypersensitivity of CCR3 in primary human eosinophils .||||||||5483..5646|40|The entire 24 kb of the CCR3 gene were screened for DNase I hypersensitivity using probes specific for Eco RI and Hind III fragments ( Figure 1A and data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5483..5646|40|The entire 24 kb of the CCR3 gene were screened for DNase I hypersensitivity using probes specific for Eco RI and Hind III fragments ( Figure 1A and data not shown ) .||||||||5648..5730|41|Only one hypersensitive site was noted ; this was in the area of exon 1 ( Figure 1B ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5648..5730|41|Only one hypersensitive site was noted ; this was in the area of exon 1 ( Figure 1B ) .||||||||5732..5833|42|Similar results were obtained with nuclei from the eosinophilic AML14 .3 D10 cell line ( data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5732..5833|42|Similar results were obtained with nuclei from the eosinophilic AML14 .3 D10 cell line ( data not shown ) .||||||||5835..5995|43|This cell line does not express CCR3 unless induced with butyric acid and IL-5 ; suggesting that chromatin remodeling in the HS1 site precedes CCR3 transcription .|||||||||||||
Implicit|||||||||||Expansion|||||||||||5997..6153|44|Thus , our analysis revealed areas of active chromatin remodeling in the vicinity of exon 1 suggesting that this area may be important for CCR3 transcription .||||||||4880..4981|45|DNase I hypersensitivity indicated that a region consistent with exon 1 is active in CCR3 transcription .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4880..4981|45|DNase I hypersensitivity indicated that a region consistent with exon 1 is active in CCR3 transcription .||||||||6262..6477|46|Together with our previous data showing that untranslated exon 1 has an important role in CCR3 transcription [ 27 ] , we hypothesized that nuclear proteins bind to exon 1 , and in turn regulate the transcription of CCR3 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6262..6477|46|Together with our previous data showing that untranslated exon 1 has an important role in CCR3 transcription [ 27 ] , we hypothesized that nuclear proteins bind to exon 1 , and in turn regulate the transcription of CCR3 .||||||||6479..6671|47|In order to test this hypothesis , a double-stranded oligonucleotide probe that corresponds to bp +10 to +60 of the CCR3 gene was prepared , referred to as E1-FL ( exon 1 - full length , Figure 2A ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6479..6671|47|In order to test this hypothesis , a double-stranded oligonucleotide probe that corresponds to bp +10 to +60 of the CCR3 gene was prepared , referred to as E1-FL ( exon 1 - full length , Figure 2A ) .||||||||6673..6736|48|This is the exact sequence that was deleted in the CCR3 ( - exon1 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6673..6736|48|This is the exact sequence that was deleted in the CCR3 ( - exon1 ) .||||||||6737..6836|49|pGL3 plasmid that demonstrated decreased activity compared to the full length 1.6 kb construct [ 27 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6737..6836|49|pGL3 plasmid that demonstrated decreased activity compared to the full length 1.6 kb construct [ 27 ] .||||||||6838..6943|50|Nuclear extracts from AML14 .3 D10 cells were incubated with the probe and resolved on a polyacrylamide gel .|||||||||||||
EntRel||||||||||||||||||||||6838..6943|50|Nuclear extracts from AML14 .3 D10 cells were incubated with the probe and resolved on a polyacrylamide gel .||||||||6945..6979|51|Two bands were visible ( Figure 2B ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6945..6979|51|Two bands were visible ( Figure 2B ) .||||||||6981..7134|52|The upper band was eliminated when 150x molar excess of the unlabelled probe was used ( CC : E1-FL in Figure 2B ) , indicating that this is the specific band .|||||||||||||
Implicit|||||||||||Expansion|||||||||||6981..7134|52|The upper band was eliminated when 150x molar excess of the unlabelled probe was used ( CC : E1-FL in Figure 2B ) , indicating that this is the specific band .||||||||7136..7344|53|In order to precisely localize the region responsible for factor binding , overlapping cold competitors were used : E1-A spanning from +10 to +31 , E1-B spanning from +25 to +46 and E1-C spanning from +40 to +60 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7136..7344|53|In order to precisely localize the region responsible for factor binding , overlapping cold competitors were used : E1-A spanning from +10 to +31 , E1-B spanning from +25 to +46 and E1-C spanning from +40 to +60 .||||||||7346..7493|54|The specific band was eliminated with E1-B and E1-C cold competitors indicating that the factor binds in the region between +25 and +60 ( Figure 2B ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7495..7631|55|In summary , these data indicate the presence of proteins in the nuclei of AML14 .3 D10 cells that bind to CCR3 exon 1 between bp 25 and 60 .||||||||7635..7779|56|In order to define the proteins capable of binding to CCR3 exon 1 , the exon 1 sequence was analyzed using the publicly available TFSEARCH engine .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7635..7779|56|In order to define the proteins capable of binding to CCR3 exon 1 , the exon 1 sequence was analyzed using the publicly available TFSEARCH engine .||||||||7781..7935|57|This analysis indicated the presence of consensus DNA-binding sites in the exon 1 region for several transcription factors ( i.e. GATA , AML1 , SRY , S8 etc. ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||7781..7935|57|This analysis indicated the presence of consensus DNA-binding sites in the exon 1 region for several transcription factors ( i.e. GATA , AML1 , SRY , S8 etc. ) .||||||||7937..8058|58|Proteins of the GATA family have been detected in eosinophils ( specifically GATA-1 , GATA-2 and low levels of GATA-3 ) [ 33 ] .|||||||||||||
Implicit|||||||||||Contingency|||||||||||8183..8266|60|Therefore , we hypothesized that proteins of the GATA family bind to sites in exon 1 .||||||||8268..8423|61|In order to address the binding of GATA proteins to CCR3 exon 1 , we prepared oligonucleotides corresponding to probe E1-B and - C with the GATA site mutated .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8268..8423|61|In order to address the binding of GATA proteins to CCR3 exon 1 , we prepared oligonucleotides corresponding to probe E1-B and - C with the GATA site mutated .||||||||8425..8630|62|As demonstrated in Figure 3A , when used as cold competitor , the GATA mutant oligonucleotide was not capable of interfering with the binding of nuclear factors to either CCR3 exon 1 probe E1-B or probe E1-C .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8632..8723|63|Additionally , we used a GATA consensus oligonucleotide with binding sites for GATA proteins .||||||||8725..8846|64|This oligonucleotide completely abolished binding of nuclear factors to both CCR3 exon 1 probes E1-B and E1-C ( Figure 3A ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8848..8993|65|Together , these data indicate that GATA proteins , present in nuclear extracts of AML14 .3 D10 cells , are capable of binding to CCR3 exon 1 sequence .||||||||8997..9218|66|In order to delineate which GATA factors are binding to exon 1 , nuclear extracts from AML14 .3 D10 cells were incubated with the radiolabelled full-length CCR3 exon 1 probe in the presence or absence of anti-GATA-1 antibody .|||||||||||||
Implicit|||||||||||Expansion|||||||||||8997..9218|66|In order to delineate which GATA factors are binding to exon 1 , nuclear extracts from AML14 .3 D10 cells were incubated with the radiolabelled full-length CCR3 exon 1 probe in the presence or absence of anti-GATA-1 antibody .||||||||9220..9375|67|As seen in Figure 3B , the GATA-1 antibody was able to interfere with the binding of the protein factor from the nuclear extracts to the radiolabelled probe .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9220..9375|67|As seen in Figure 3B , the GATA-1 antibody was able to interfere with the binding of the protein factor from the nuclear extracts to the radiolabelled probe .||||||||9377..9629|68|In order to more precisely localize to which part of exon 1 GATA-1 is capable of binding , overlapping oligonucleotide probes were radiolabelled and incubated with nuclear extracts from AML14 .3 D10 cells in the presence and absence of the GATA-1 antibody .|||||||||||||
EntRel||||||||||||||||||||||9377..9629|68|In order to more precisely localize to which part of exon 1 GATA-1 is capable of binding , overlapping oligonucleotide probes were radiolabelled and incubated with nuclear extracts from AML14 .3 D10 cells in the presence and absence of the GATA-1 antibody .||||||||9631..9735|69|This treatment efficiently inhibited the binding of probes E1-B and - C to the nuclear factor ( Figure 3C ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9737..9905|70|These data indicate that GATA-1 , present in nuclear extracts of AML14 .3 D10 cells , is at least one of the factors capable of binding the CCR3 exon 1 between bp 25 and 60 .||||||||2620..2689|71|We have previously characterized the human CCR3 promoter in vitro [ 27 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||2620..2689|71|We have previously characterized the human CCR3 promoter in vitro [ 27 ] .||||||||9981..10193|72|In order to determine if this region had promoter activity in vivo and to assess cell-specificity , we generated transgenic mice expressing the reporter gene EGFP under the control of the CCR3 promoter ( Figure 4A ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||9981..10193|72|In order to determine if this region had promoter activity in vivo and to assess cell-specificity , we generated transgenic mice expressing the reporter gene EGFP under the control of the CCR3 promoter ( Figure 4A ) .||||||||10195..10283|73|1.6 kb of the promoter and 60 base pairs of exon 1 were cloned upstream of the EGFP gene .|||||||||||||
EntRel||||||||||||||||||||||10195..10283|73|1.6 kb of the promoter and 60 base pairs of exon 1 were cloned upstream of the EGFP gene .||||||||10285..10331|74|Seven transgenic founder lines were identified .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10285..10331|74|Seven transgenic founder lines were identified .||||||||10333..10517|75|Two of the founder lines did not transmit the transgene to their offspring and one line did not show transgene expression as determined by Northern blotting and RT-PCR ( data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10333..10517|75|Two of the founder lines did not transmit the transgene to their offspring and one line did not show transgene expression as determined by Northern blotting and RT-PCR ( data not shown ) .||||||||10519..10628|76|In four of the lines the level and pattern of transgene expression varied suggesting integration site effects .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10519..10628|76|In four of the lines the level and pattern of transgene expression varied suggesting integration site effects .||||||||10630..10724|77|Two of the lines ( 4.1 and 4.2 ) displayed minimal mRNA expression and were not further analyzed .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10726..10832|78|In contrast , the other two lines ( 3.1 and 3.2 ) showed high expression of the transgene in multiple tissues .||||||||10834..11070|79|Line 3.1 displayed varying levels of mRNA expression in all organs tested : lungs , kidneys , jejunum , thymus , bone marrow , and spleen , with highest expression in the thymus ( by Northern blot analysis , Figure 4B and RT-PCR , data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||10834..11070|79|Line 3.1 displayed varying levels of mRNA expression in all organs tested : lungs , kidneys , jejunum , thymus , bone marrow , and spleen , with highest expression in the thymus ( by Northern blot analysis , Figure 4B and RT-PCR , data not shown ) .||||||||11072..11178|80|While we expected the transcript to be about 1 kb in size ( Figure 4A ) , two bands ~ 4 and 5 kb were apparent .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11072..11178|80|While we expected the transcript to be about 1 kb in size ( Figure 4A ) , two bands ~ 4 and 5 kb were apparent .||||||||11180..11329|81|Since this was not the case with other lines , we suspect it is integration-site specific and another gene may have been transcribed together with GFP .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11331..11589|82|However , the size of the RT-PCR amplified fragment was of the expected size and the protein was detectable by immunohistochemistry ( see below ) thus implying that this did not affect the translation of the protein and integrity of the epitope for the antibody .||||||||11591..11720|83|Expression in the lungs , jejunum , thymus and kidney was confirmed by anti-GFP immunohistochemistry ( Figure 4C and data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11591..11720|83|Expression in the lungs , jejunum , thymus and kidney was confirmed by anti-GFP immunohistochemistry ( Figure 4C and data not shown ) .||||||||11722..11801|84|In the jejunum , staining was present predominantly in stromal cells ( Figure 4C ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11722..11801|84|In the jejunum , staining was present predominantly in stromal cells ( Figure 4C ) .||||||||11803..11914|85|Of note , eosinophils normally reside in the gastrointestinal tract and are located in the stroma of the jejunum .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11916..12131|86|However , in the lungs , which are normally devoid of eosinophils at baseline , there was GFP expression that was confined to the alveolar lining consistent with predominant expression in type I pneumocytes ( Figure 4C ) .||||||||12133..12251|87|In the thymus , compared to staining without primary antibody ( data not shown ) , all thymocytes stained positive for GFP .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12253..12353|88|Additionally , in the kidney all cells were positive , both in the medulla and cortex ( data not shown ) .||||||||12355..12417|89|Line 3.2 displayed a different pattern of transgene expression .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12355..12417|89|Line 3.2 displayed a different pattern of transgene expression .||||||||11009..11145|90|Northern blot analysis revealed expression in multiple organs with the lungs and kidneys expressing the highest levels ( Figure 4B ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||11009..11145|90|Northern blot analysis revealed expression in multiple organs with the lungs and kidneys expressing the highest levels ( Figure 4B ) .||||||||12551..12719|91|Consistent with this , protein was detected by immunohistochemistry at high levels in lungs and kidneys and only marginally in the jejunum ( Figure 4C and data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12551..12719|91|Consistent with this , protein was detected by immunohistochemistry at high levels in lungs and kidneys and only marginally in the jejunum ( Figure 4C and data not shown ) .||||||||12721..12861|92|While staining in the lungs was comparable to line 3.1 , only a minority of stromal cells and no epithelial cells were stained in the jejunum .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12721..12861|92|While staining in the lungs was comparable to line 3.1 , only a minority of stromal cells and no epithelial cells were stained in the jejunum .||||||||12863..12994|93|In the kidney , almost all cells expressed the transgene in the medulla , while in the cortex staining was prominent in the glomeruli .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12863..12994|93|In the kidney , almost all cells expressed the transgene in the medulla , while in the cortex staining was prominent in the glomeruli .||||||||12996..13065|94|There was no anti-GFP staining observed in wild type mice ( Figure 4C ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||12996..13065|94|There was no anti-GFP staining observed in wild type mice ( Figure 4C ) .||||||||13067..13180|95|No changes in expression were found when the transgene was crossed with CD2.IL-5 transgenic mice ( data not shown ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13067..13180|95|No changes in expression were found when the transgene was crossed with CD2.IL-5 transgenic mice ( data not shown ) .||||||||13182..13284|96|In summary , the 1.6 kb of the 5 ' flanking region of the CCR3 gene has strong promoter activity in vivo .|||||||||||||
Implicit|||||||||||Expansion|||||||||||13645..13766|100|Furthermore , nuclear proteins derived from eosinophilic cells were shown to bind CCR3 exon between nucleotides +25 to +60 .||||||||13768..13896|101|Using unlabelled competitors and antibodies , proteins of the GATA family , specifically GATA-1 , were shown to bind to this region .|||||||||||||
EntRel||||||||||||||||||||||13768..13896|101|Using unlabelled competitors and antibodies , proteins of the GATA family , specifically GATA-1 , were shown to bind to this region .||||||||13898..14014|102|Taken together , these data suggest that untranslated exon 1 , via GATA-1 , has a regulatory role in CCR3 transcription .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14016..14126|103|Finally , we demonstrate that the 1.6-kb CCR3 promoter element , that includes exon 1 , is broadly active in vivo .||||||||14130..14180|104|The HS1 site was located in the vicinity of exon 1 .|||||||||||||
Implicit|||||||||||Contingency|||||||||||14130..14180|104|The HS1 site was located in the vicinity of exon 1 .||||||||14182..14391|105|Combined with our previous results demonstrating diminished promoter activity when exon 1 is deleted from the promoter construct , these data suggested that 5 ' untranslated exon 1 may have a regulatory function .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14182..14391|105|Combined with our previous results demonstrating diminished promoter activity when exon 1 is deleted from the promoter construct , these data suggested that 5 ' untranslated exon 1 may have a regulatory function .||||||||3955..4072|106|It has been reported that the 5 ' untranslated exons may contain sequences that facilitate transcription of the gene .|||||||||||||
Implicit|||||||||||Expansion|||||||||||3955..4072|106|It has been reported that the 5 ' untranslated exons may contain sequences that facilitate transcription of the gene .||||||||4425..4606|107|Examples include a GATA-1 site in the 5 ' - UTR of the γ-globin gene , an HNF-1 site in the plasminogen gene , a PU .1 site in the PU .1 gene and a C/EBP site in the CCR2 gene [ 24,31,32,35 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||14694..14752|108|Thus , we hypothesized that nuclear proteins bind to exon 1 .||||||||14754..14915|109|Our EMSA analysis , coupled with cold competitors and specific antibodies , indicates that proteins of the GATA family , specifically GATA-1 bind to the CCR3 exon 1 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15097..15152|112|These possibilities will be addressed in future studies .||||||||15156..15328|113|It is important that this data be viewed with what is known about other myeloid-specific promoters , that have often proven to be difficult to function independently in vivo .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15330..15542|114|For example , constructs using the 5 ' flanking region of myeloid-specific genes have not been useful for transgenic work ( such as the CD14 promoter [ 36 ] , the c-kit promoter [ 37 ] , or the 1.7 kb CD11b promoter [ 38 ] ) .||||||||15544..15727|115|Better success was obtained when the entire gene , including the open reading frame , was used ( e.g. the human cathepsin G , chicken lysozyme and c-fps/fes transgenic constructs [ 39-41 ] ) .|||||||||||||
EntRel||||||||||||||||||||||15544..15727|115|Better success was obtained when the entire gene , including the open reading frame , was used ( e.g. the human cathepsin G , chicken lysozyme and c-fps/fes transgenic constructs [ 39-41 ] ) .||||||||15729..15854|116|These constructs were at least 6 kb in size and contained all exons and introns and several kb of 5 ' and 3 ' flanking sequence .|||||||||||||
Implicit|||||||||||Expansion|||||||||||15729..15854|116|These constructs were at least 6 kb in size and contained all exons and introns and several kb of 5 ' and 3 ' flanking sequence .||||||||15856..16029|117|Presumably , these larger constructs contained the locus control region ( LCR ) - sequences that have the ability to dominantly control gene expression in any chromosomal region .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16031..16206|118|This in turn allows for a high degree of consistency among independent mouse lines with regard to cell specificity , level of expression and proportionality to gene copy number .||||||||16208..16421|119|These regions may be located at several different sites in the gene , including introns and coding exons ; thus , screening with DNase I hypersensitivity is usually the first method employed to identify these regions .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16208..16421|119|These regions may be located at several different sites in the gene , including introns and coding exons ; thus , screening with DNase I hypersensitivity is usually the first method employed to identify these regions .||||||||16423..16625|120|Transgenic mice expressing the EGFP reporter gene under the control of the CCR3 promoter demonstrate that the 1.6 kb promoter and 60 bp of exon 1 of the CCR3 gene confer strong promoter activity in vivo .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16627..16762|121|However , these sequences do not contain the entire LCR , since expression of the reporter gene was variable among multiple founder lines .||||||||4880..4965|122|DNase I hypersensitivity studies discovered one hypersensitive site in the CCR3 locus .|||||||||||||
Implicit|||||||||||Expansion|||||||||||4880..4965|122|DNase I hypersensitivity studies discovered one hypersensitive site in the CCR3 locus .||||||||16851..16988|123|The HS1 site was apparently not sufficient for integration-site independent effects , since it is contained in the promoter construct used .|||||||||||||
Implicit|||||||||||Expansion|||||||||||16990..17059|124|Thus , future studies will need to broaden the search for the CCR3 LCR .||||||||17061..17152|125|It is important to note that the true cellular specificity of CCR3 has not been established .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17061..17152|125|It is important to note that the true cellular specificity of CCR3 has not been established .||||||||17154..17509|126|While this gene product is often considered to be specific for inflammatory cells involved in allergic inflammation ( eosinophils , mast cells , and possibly Th2 cells ) , several reports have documented expression by other cell types including additional leukocytes ( e.g. dendritic cells ) , as well as tissue cells ( epithelial and endothelial cells ) [ 11-16 ,42 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17511..17653|127|Thus , it remains to be determined if our observation that the CCR3 promoter has broad activity in vivo represents the true endogenous activity .||||||||17657..17871|128|Since CCR3 is expressed strongly on eosinophils , analysis of the signals that induce its expression may give insight into the molecular mechanisms for the commitment of myeloid progenitors to the eosinophil lineage .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17657..17871|128|Since CCR3 is expressed strongly on eosinophils , analysis of the signals that induce its expression may give insight into the molecular mechanisms for the commitment of myeloid progenitors to the eosinophil lineage .||||||||17873..18127|129|It is generally believed that transcription factors are the final common pathway driving differentiation and that hematopoietic commitment to different lineages is driven by alternative expression of specific combinations of transcription factors [ 43,44 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||17873..18127|129|It is generally believed that transcription factors are the final common pathway driving differentiation and that hematopoietic commitment to different lineages is driven by alternative expression of specific combinations of transcription factors [ 43,44 ] .||||||||18129..18294|130|Although no eosinophil-specific transcription factors have been reported , eosinophil commitment appears to be regulated by GATA-1 , PU-1 and C/EBP proteins [ 34,45-48 ] .|||||||||||||
Implicit|||||||||||Expansion|||||||||||18129..18294|130|Although no eosinophil-specific transcription factors have been reported , eosinophil commitment appears to be regulated by GATA-1 , PU-1 and C/EBP proteins [ 34,45-48 ] .||||||||12551..12812|131|Consistent with this , DNA binding sites for these transcription factors are found in several eosinophil-selective promoters , such as the promoter for major basic protein ( MBP ) , IL-5 receptor alpha ( IL-5Rα ) chain and Charcot-Leyden crystal ( CLC ) protein .|||||||||||||
Implicit|||||||||||Expansion|||||||||||19634..19782|136|Eosinophils were isolated by anti-CD16 negative selection from granulocyte preparations of healthy or atopic volunteers as described previously [ 51 ] .||||||||19786..20111|137|Nuclei were derived from cell lines and primary cells using a polyamine buffer containing 0.34 M sucrose , 13.3 mM Tris ( pH7 .5 ) , 53.2 mM KCl , 13.3 mM NaCl , 2 mM EDTA , 0.5 mM EGTA , 0.133 mM spermine , 0.5 mM spermidine , 0.1 % TritonX-100 , 2 mM MgCl2 and freshly prepared 2-mercaptoethanol and phenylmethylsulfonyl fluoride ( PMSF ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20113..20346|138|Nuclei were then centrifuged at 2300 g for 30 min over a cushion of 1.2 M sucrose and washed twice prior to resuspension in DNase I digestion buffer ( 60 mM KCl , 5 mM MgCl2 , 15 mM Tris ( pH7 .5 ) , 0.1 mM EGTA , 0.5 mM DTT and 5 % glycerol ) .||||||||20348..20664|139|Nuclei were resuspended at a concentration of 2 – 4 × 106 nuclei/ml and gentle DNase I digestion was carried out in a volume of 0.2 ml with 0 to 100 units of DNase I ( Roche ) for 5 minutes at 30 ° C. Following DNase I treatment , nuclei were lysed and DNA purified by phenol/chloroform extraction and ethanol precipitation .|||||||||||||
Implicit|||||||||||Expansion|||||||||||20348..20664|139|Nuclei were resuspended at a concentration of 2 – 4 × 106 nuclei/ml and gentle DNase I digestion was carried out in a volume of 0.2 ml with 0 to 100 units of DNase I ( Roche ) for 5 minutes at 30 ° C. Following DNase I treatment , nuclei were lysed and DNA purified by phenol/chloroform extraction and ethanol precipitation .||||||||20666..20783|140|DNA was digested with appropriate restriction enzymes ( Eco RI and Hind III ) and electrophoresed on a 0.8 % agarose gel .|||||||||||||
EntRel||||||||||||||||||||||20666..20783|140|DNA was digested with appropriate restriction enzymes ( Eco RI and Hind III ) and electrophoresed on a 0.8 % agarose gel .||||||||20785..20877|141|Following transfer to nylon membranes , hybridization was performed using standard procedures .|||||||||||||
Implicit|||||||||||Temporal|||||||||||20785..20877|141|Following transfer to nylon membranes , hybridization was performed using standard procedures .||||||||20879..20928|142|Probe fragments were made by PCR from genomic DNA .|||||||||||||
EntRel||||||||||||||||||||||20930..21066|143|Figure 1 depicts the CCR3 gene structure and restriction fragments and their corresponding probes that were used to span the entire gene .||||||||21070..21159|144|Cultured cells were washed twice with ice cold phosphate buffered saline ( PBS , Gibco BRL ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21070..21159|144|Cultured cells were washed twice with ice cold phosphate buffered saline ( PBS , Gibco BRL ) .||||||||21161..21456|145|2.5 × 106 cells were lysed in lysis buffer [ 100 mM N-2-hydroxyethylpiperazine-N ' -2 - ethanesulfonic acid ( HEPES ) , pH 7.9 , 10 mM KCl , 0.1 mM EDTA , 1.5 mM MgCl2 , 0.2 % Nonidet P-40 , 1 mM dithiothreitol ( DTT ) , and 0.5 mM PMSF ] , briefly vortexed at a moderate speed , then incubated on ice for 5 minutes .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21161..21456|145|2.5 × 106 cells were lysed in lysis buffer [ 100 mM N-2-hydroxyethylpiperazine-N ' -2 - ethanesulfonic acid ( HEPES ) , pH 7.9 , 10 mM KCl , 0.1 mM EDTA , 1.5 mM MgCl2 , 0.2 % Nonidet P-40 , 1 mM dithiothreitol ( DTT ) , and 0.5 mM PMSF ] , briefly vortexed at a moderate speed , then incubated on ice for 5 minutes .||||||||21458..21703|146|Sample was centrifuged and the pellet was next resuspended in 20 μl of extraction buffer ( 20 mM HEPES , pH 7.9 , 420 mM NaCl , 0.1 mM EDTA , 1.5 mM MgCl2 , 25 % glycerol , 1 mM DTT , and 0.5 mM PMSF ) , mildly vortexed , and incubated on ice for 15 minutes .|||||||||||||
Implicit|||||||||||Expansion|||||||||||21458..21703|146|Sample was centrifuged and the pellet was next resuspended in 20 μl of extraction buffer ( 20 mM HEPES , pH 7.9 , 420 mM NaCl , 0.1 mM EDTA , 1.5 mM MgCl2 , 25 % glycerol , 1 mM DTT , and 0.5 mM PMSF ) , mildly vortexed , and incubated on ice for 15 minutes .||||||||21705..21758|147|Samples were centrifuged to pellet the nuclear debris .|||||||||||||
EntRel||||||||||||||||||||||21760..21862|148|Supernatants were placed in silicon coated microcentrifuge tubes and stored at -80 ° C until further use .||||||||21866..22035|149|Single-stranded oligonucleotides based on the sequence of untranslated exon 1 of the CCR3 promoter were synthesized by Integrated DNA Technologies , Inc. ( Coralville , IA ) .|||||||||||||
EntRel||||||||||||||||||||||21866..22035|149|Single-stranded oligonucleotides based on the sequence of untranslated exon 1 of the CCR3 promoter were synthesized by Integrated DNA Technologies , Inc. ( Coralville , IA ) .||||||||22037..22283|150|One full length 51 base pair ( +10 to +60 ) oligonucleotide ( GGTACCACTGGTCTTCTTGTGCTTATCCGGGCAAGAACTTATCGAAATACA ) and three overlapping oligonucleotides ( +10 to +31 , +25 to +46 , and +40 to +60 ) and their reverse complements were produced ( Figure 2 ) .|||||||||||||
EntRel||||||||||||||||||||||22037..22283|150|One full length 51 base pair ( +10 to +60 ) oligonucleotide ( GGTACCACTGGTCTTCTTGTGCTTATCCGGGCAAGAACTTATCGAAATACA ) and three overlapping oligonucleotides ( +10 to +31 , +25 to +46 , and +40 to +60 ) and their reverse complements were produced ( Figure 2 ) .||||||||22285..22368|151|Two of the overlapping fragments contained putative GATA binding sites ( underlined ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22370..22463|152|Two mutants and their complements were also made which changed the GATA sequence TATC to TTGA .||||||||22465..22676|153|This mutation does not change the GC content of the oligonucleotides , nor does it create a new transcription factor site for any of the transcription factors represented in the publicly available TFSEARCH engine .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22465..22676|153|This mutation does not change the GC content of the oligonucleotides , nor does it create a new transcription factor site for any of the transcription factors represented in the publicly available TFSEARCH engine .||||||||22678..22803|154|Each oligonucleotide was resuspended to a concentration of 50 μM in TE buffer ( 10 mM Tris-Cl , pH 7.4 , and 0.1 mM EDTA , Sigma ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22678..22803|154|Each oligonucleotide was resuspended to a concentration of 50 μM in TE buffer ( 10 mM Tris-Cl , pH 7.4 , and 0.1 mM EDTA , Sigma ) .||||||||22805..23040|155|Complimentary single-stranded oligonucleotides were annealed at a concentration of 10 mM in restriction enzyme buffer M ( 10 mM Tris-Cl , 10 mM MgCl2 , 50 mM NaCl , and 1 mM dithioerythritol , Roche Molecular Biochemicals , Indianapolis , IN ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||22805..23040|155|Complimentary single-stranded oligonucleotides were annealed at a concentration of 10 mM in restriction enzyme buffer M ( 10 mM Tris-Cl , 10 mM MgCl2 , 50 mM NaCl , and 1 mM dithioerythritol , Roche Molecular Biochemicals , Indianapolis , IN ) .||||||||23042..23192|156|Samples were placed in a 95 ° C dry heat block for 5 minutes and then the block was removed from the unit and allowed to cool slowly to room temperature .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23042..23192|156|Samples were placed in a 95 ° C dry heat block for 5 minutes and then the block was removed from the unit and allowed to cool slowly to room temperature .||||||||23194..23376|157|The double-stranded oligomers were diluted to 1 μM with TE buffer and 30 ng were end-labelled using [ γ-32P ] ATP ( NEN Life Science , Boston , MA ) and T4 polynucleotide kinase ( Gibco BRL ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23378..23477|158|Probe was purified over Quick Spin G-25 Sephadex columns ( Roche ) and recovered in a volume of 50 μl .||||||||23481..23589|159|Protein content of the nuclear extracts were determined by Bradford ( Coomassie ) assay ( Pierce , Rockford , IL ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23481..23589|159|Protein content of the nuclear extracts were determined by Bradford ( Coomassie ) assay ( Pierce , Rockford , IL ) .||||||||23591..23875|160|Total protein ( 5 μg ) was incubated on ice for 10 minutes with 2X EMSA buffer ( 24 % glycerol , 0.08 μg / ml poly dI-dC , 24 mM HEPES , pH 7.9 , 8 mM Tris-Cl , pH 7.9 , 2 mM EDTA , 2 mM DTT , 50 mM KCl , and 10 mM MgCl2 , ) , and when indicated , with 150 fold excess of cold competitor oligonucleotide .|||||||||||||
EntRel||||||||||||||||||||||23591..23875|160|Total protein ( 5 μg ) was incubated on ice for 10 minutes with 2X EMSA buffer ( 24 % glycerol , 0.08 μg / ml poly dI-dC , 24 mM HEPES , pH 7.9 , 8 mM Tris-Cl , pH 7.9 , 2 mM EDTA , 2 mM DTT , 50 mM KCl , and 10 mM MgCl2 , ) , and when indicated , with 150 fold excess of cold competitor oligonucleotide .||||||||23877..23988|161|Radiolabelled oligo probe was added to each sample and incubation continued for an additional 10 minutes on ice .|||||||||||||
Implicit|||||||||||Expansion|||||||||||23877..23988|161|Radiolabelled oligo probe was added to each sample and incubation continued for an additional 10 minutes on ice .||||||||23990..24184|162|For antibody supershift assays , anti-GATA-1 antibody ( clone C20 , Santa Cruz Biotechnology , Santa Cruz , CA ) was added following the addition of the probe and samples incubated on ice for one hour .|||||||||||||
EntRel||||||||||||||||||||||23990..24184|162|For antibody supershift assays , anti-GATA-1 antibody ( clone C20 , Santa Cruz Biotechnology , Santa Cruz , CA ) was added following the addition of the probe and samples incubated on ice for one hour .||||||||24186..24270|163|In control experiments , isotype-control antibodies did not have a significant effect .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24528..24587|165|Gels were dried on blotting paper and exposed to x-ray film .||||||||24591..24721|166|1.6 kb of the CCR3 promoter , including 60 bp of untranslated exon 1 , was subcloned into the pEGFP vector ( Clontech , Palo Alto , CA ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||24591..24721|166|1.6 kb of the CCR3 promoter , including 60 bp of untranslated exon 1 , was subcloned into the pEGFP vector ( Clontech , Palo Alto , CA ) .||||||||24723..25070|167|The transgenic construct containing the promoter , reporter gene enhanced green fluorescent probe ( EGFP ) and the SV40 polyadenylation signal ( Figure 4 ) were liberated by Afl II and Hind III digestion and injected into the pronucleus of fertilized eggs from FVB/N mice by the Transgenic Core Facility at Cincinnati Children 's Hospital Medical Center .|||||||||||||
EntRel||||||||||||||||||||||24723..25070|167|The transgenic construct containing the promoter , reporter gene enhanced green fluorescent probe ( EGFP ) and the SV40 polyadenylation signal ( Figure 4 ) were liberated by Afl II and Hind III digestion and injected into the pronucleus of fertilized eggs from FVB/N mice by the Transgenic Core Facility at Cincinnati Children 's Hospital Medical Center .||||||||25072..25199|168|Transgenic mice were identified by Southern blot analysis after digestion with BamHI , using the SV40 poly A fragment as a probe .|||||||||||||
Implicit|||||||||||Contingency|||||||||||25072..25199|168|Transgenic mice were identified by Southern blot analysis after digestion with BamHI , using the SV40 poly A fragment as a probe .||||||||25201..25301|169|Lines were tested for expression of the transgene in multiple organs by Northern blotting and RT-PCT .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25201..25301|169|Lines were tested for expression of the transgene in multiple organs by Northern blotting and RT-PCT .||||||||25303..25369|170|The SV40 poly A fragment was used as a probe for Northern blotting .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25303..25369|170|The SV40 poly A fragment was used as a probe for Northern blotting .||||||||25371..25460|171|PCR primers for EGFP were as follows : 5 ' ATGGTGAGCCAAGGGCGAG3 ' and 5 ' CTTGTACAGCTCGTCCATG3 ' .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25371..25460|171|PCR primers for EGFP were as follows : 5 ' ATGGTGAGCCAAGGGCGAG3 ' and 5 ' CTTGTACAGCTCGTCCATG3 ' .||||||||25462..25561|172|RNA integrity and RT efficiency was verified by performing PCR for β-actin on the same cDNA samples .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25563..25656|173|Primers used were as follows : 5 ' GGAATCCTGTGGCATCCATGAAACT3 ' and 5 ' TAAAACGCAGCTCAGTAACAGTCCG3 ' .||||||||25660..25743|174|Immunohistochemistry was performed on frozen sections essentially as described [ 52 ] .|||||||||||||
Implicit|||||||||||Temporal|||||||||||25660..25743|174|Immunohistochemistry was performed on frozen sections essentially as described [ 52 ] .||||||||25745..25925|175|Briefly , following endogenous peroxidase quenching , slides were blocked and stained with a rabbit-anti-GFP antibody ( AB3080 at 1:400 dilution , Chemicon International , Temecula , CA ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||25745..25925|175|Briefly , following endogenous peroxidase quenching , slides were blocked and stained with a rabbit-anti-GFP antibody ( AB3080 at 1:400 dilution , Chemicon International , Temecula , CA ) .||||||||25927..26096|176|The slides were washed and incubated with biotinylated goat anti-rabbit antibody and avidin-peroxidase complex ( Vectastain ABC Peroxidase Elite kit , Vector Laboratories ) .|||||||||||||
EntRel||||||||||||||||||||||26261..26318|178|Authors ' contributions JLC carried out the EMSA analysis .||||||||26320..26368|179|LEK performed the DNAse hypersensitivity studies .|||||||||||||
EntRel||||||||||||||||||||||26320..26368|179|LEK performed the DNAse hypersensitivity studies .||||||||26370..26524|180|NZ carried out the generation and analysis of transgenic mice , participated in the design and coordination of the overall study and drafted the manuscript .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26633..26702|182|Figure and Table captions Figure 1 : DNase I hypersensitivity studies .||||||||26704..26764|183|In ( A ) , a schematic representation of the CCR3 gene is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26704..26764|183|In ( A ) , a schematic representation of the CCR3 gene is shown .||||||||26766..26916|184|Exons 1 through 4 ( E1 – E4 ) are depicted as boxes ; open box represents the open reading frame , while the closed box represents the untranslated region .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26766..26916|184|Exons 1 through 4 ( E1 – E4 ) are depicted as boxes ; open box represents the open reading frame , while the closed box represents the untranslated region .||||||||26918..27098|185|The position of Hind III ( H ) and Eco RI ( RI ) restriction sites is depicted with arrows and probes used for DNase I hypersensitivity are depicted as lines above the genomic fragment .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26918..27098|185|The position of Hind III ( H ) and Eco RI ( RI ) restriction sites is depicted with arrows and probes used for DNase I hypersensitivity are depicted as lines above the genomic fragment .||||||||27100..27154|186|The position of hypersensitive site is depicted as HS1 .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27100..27154|186|The position of hypersensitive site is depicted as HS1 .||||||||27156..27211|187|In ( B ) , Southern blot analysis for the HS site is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27156..27211|187|In ( B ) , Southern blot analysis for the HS site is shown .||||||||27213..27495|188|Nuclei from the primary human eosinophils were digested with indicated doses of DNase I for 5 minutes at 30 ° C. Following DNA purification and digestion with restriction enzymes ( shown in figure is Eco RI ) , DNA was electrophoresed on an agarose gel and transferred to nylon membranes .|||||||||||||
EntRel||||||||||||||||||||||27213..27495|188|Nuclei from the primary human eosinophils were digested with indicated doses of DNase I for 5 minutes at 30 ° C. Following DNA purification and digestion with restriction enzymes ( shown in figure is Eco RI ) , DNA was electrophoresed on an agarose gel and transferred to nylon membranes .||||||||27497..27572|189|Following hybridization with genomic probes , membranes were exposed to film .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27497..27572|189|Following hybridization with genomic probes , membranes were exposed to film .||||||||27574..27609|190|Size markers are shown on the right .|||||||||||||
EntRel||||||||||||||||||||||27611..27661|191|Ethidium bromide staining of the gel is also shown .||||||||27664..27721|192|Figure 2 : Binding of transcription factors to CCR3 exon 1 .|||||||||||||
EntRel||||||||||||||||||||||27664..27721|192|Figure 2 : Binding of transcription factors to CCR3 exon 1 .||||||||26704..26824|193|In ( A ) , a schematic representation of the CCR3 exon region used for electrophoretic mobility shift assays is shown .|||||||||||||
EntRel||||||||||||||||||||||26704..26824|193|In ( A ) , a schematic representation of the CCR3 exon region used for electrophoretic mobility shift assays is shown .||||||||27839..27876|194|E1-FL is the exon 1 full-length probe .|||||||||||||
EntRel||||||||||||||||||||||27839..27876|194|E1-FL is the exon 1 full-length probe .||||||||27878..27947|195|Overlapping short probes are called E1-A , E1-B and E1-C , respectively .|||||||||||||
EntRel||||||||||||||||||||||27878..27947|195|Overlapping short probes are called E1-A , E1-B and E1-C , respectively .||||||||27949..27996|196|The DNA sequence is shown with GATA sites boxed .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27949..27996|196|The DNA sequence is shown with GATA sites boxed .||||||||27998..28100|197|In ( B ) , EMSA assay with the full-length probe and extracts from eosinophilic AML14 .3 D10 cells is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27998..28100|197|In ( B ) , EMSA assay with the full-length probe and extracts from eosinophilic AML14 .3 D10 cells is shown .||||||||28102..28191|198|As cold competitors ( CC ) , the full-length probe and short probes E1-A through C were used .|||||||||||||
EntRel||||||||||||||||||||||28102..28191|198|As cold competitors ( CC ) , the full-length probe and short probes E1-A through C were used .||||||||28193..28228|199|The arrow depicts the specific band .|||||||||||||
EntRel||||||||||||||||||||||28230..28297|200|A representative experiment , of three similar experiments , is shown .||||||||28300..28348|201|Figure 3 : Binding of GATA factors to CCR3 exon 1 .|||||||||||||
EntRel||||||||||||||||||||||28300..28348|201|Figure 3 : Binding of GATA factors to CCR3 exon 1 .||||||||28350..28473|202|In ( A ) , EMSA assay with probes E1-B ( left panel ) and E1-C ( right panel ) and nuclear extracts from AML14 .3 D10 cells is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||28350..28473|202|In ( A ) , EMSA assay with probes E1-B ( left panel ) and E1-C ( right panel ) and nuclear extracts from AML14 .3 D10 cells is shown .||||||||28475..28701|203|Three cold competitors were used in each case : the probe itself ( E1-B-WT and E1-C-WT , respectively ) , the probe with the GATA site mutated ( E1-B-mut and E1-C-mut , respectively ) and the GATA consensus oligonucleotide ( GATA cons ) .|||||||||||||
EntRel||||||||||||||||||||||28475..28701|203|Three cold competitors were used in each case : the probe itself ( E1-B-WT and E1-C-WT , respectively ) , the probe with the GATA site mutated ( E1-B-mut and E1-C-mut , respectively ) and the GATA consensus oligonucleotide ( GATA cons ) .||||||||28230..28297|204|A representative experiment , of three similar experiments , is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||28230..28297|204|A representative experiment , of three similar experiments , is shown .||||||||27998..28164|205|In ( B ) , EMSA assay with the full-length probe ( E1-FL ) and extracts from eosinophilic AML14 .3 D10 cells in the presence or absence of antibodies against GATA-1 is shown .|||||||||||||
EntRel||||||||||||||||||||||27998..28164|205|In ( B ) , EMSA assay with the full-length probe ( E1-FL ) and extracts from eosinophilic AML14 .3 D10 cells in the presence or absence of antibodies against GATA-1 is shown .||||||||28193..28228|206|The arrow depicts the specific band .|||||||||||||
EntRel||||||||||||||||||||||28977..29208|207|In ( C ) , EMSA assay with probes E1-B ( left panel ) and E1-C ( right panel ) and nuclear extracts from AML14 .3 D10 cells and cold competitor probe itself ( CC : E1-B and CC : E1-C , respectively ) or anti-GATA-1 antibody ( GATA-1 atb ) is shown .||||||||29211..29250|208|Figure 4 : The CCR3/EGFP transgenic mice .|||||||||||||
EntRel||||||||||||||||||||||29211..29250|208|Figure 4 : The CCR3/EGFP transgenic mice .||||||||26704..26778|209|In ( A ) , a schematic representation of the transgenic construct is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||26704..26778|209|In ( A ) , a schematic representation of the transgenic construct is shown .||||||||29325..29509|210|The genomic fragment encoding 1.6 kb of the CCR3 promoter including 60 bp of exon 1 ( E1 ) , was cloned into the Hind III and Bam HI sites upstream from the EGFP gene in the pEGFP1 vector .|||||||||||||
EntRel||||||||||||||||||||||29325..29509|210|The genomic fragment encoding 1.6 kb of the CCR3 promoter including 60 bp of exon 1 ( E1 ) , was cloned into the Hind III and Bam HI sites upstream from the EGFP gene in the pEGFP1 vector .||||||||29511..29559|211|The positions of restriction sites are indicated .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29511..29559|211|The positions of restriction sites are indicated .||||||||29561..29641|212|In ( B ) , Northern blot analysis of multiple tissues from transgenic mice is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29561..29641|212|In ( B ) , Northern blot analysis of multiple tissues from transgenic mice is shown .||||||||29643..29758|213|RNA was isolated from the spleen , lung , thymus , kidney and jejunum of CCR3/EGFP transgenic mice ( lines 3.1 and 3.2 ) .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29643..29758|213|RNA was isolated from the spleen , lung , thymus , kidney and jejunum of CCR3/EGFP transgenic mice ( lines 3.1 and 3.2 ) .||||||||29760..29929|214|10 μg total RNA was electrophoresed on an agarose gel , transferred to nylon membranes and probed with the SV40 polyA probe in order to detect expression of the transgene .|||||||||||||
Implicit|||||||||||Expansion|||||||||||29760..29929|214|10 μg total RNA was electrophoresed on an agarose gel , transferred to nylon membranes and probed with the SV40 polyA probe in order to detect expression of the transgene .||||||||29931..29978|215|Position of 28S and 18S is depicted with arrows .|||||||||||||
Implicit|||||||||||Expansion|||||||||||27611..27661|216|Ethidium bromide staining of the gel is also shown .||||||||30032..30096|217|In ( C ) , immunohistochemistry using an anti-GFP antibody is shown .|||||||||||||
Implicit|||||||||||Expansion|||||||||||30032..30096|217|In ( C ) , immunohistochemistry using an anti-GFP antibody is shown .||||||||30098..30189|218|Organs were collected , frozen sections obtained and anti-GFP immunohistochemistry performed .|||||||||||||
EntRel||||||||||||||||||||||30098..30189|218|Organs were collected , frozen sections obtained and anti-GFP immunohistochemistry performed .||||||||30191..30244|219|Positive staining is represented as black precipitate .|||||||||||||
